The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EMN 2018 | CAR T-cells for mulitple myeloma
Fabio Malavasi
• 19 Apr 2018
In this video, Fabio Malavasi, MD, of the University of Turin, Turin, Italy, discusses immunotherapy in multiple myeloma (MM) from the 1st European Myeloma Network Meeting (EMN) 2018, in Turin, Italy. Prof. Malavasi highlights the innovative apporach of CAR T-cells, before mentioning the current limitations preventing the further development and application of this treatment.
